{{cart_num}}
My Cart> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > Halofuginone lactateCAS：82186-71-8
Molecular Formula：C16H18Br2ClN3O3
Molecular Weight：495.59
Storage：Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year
Purity：≥98%
Appearance：White to off-white Solid
Qty：
Size：
| CAS | 82186-71-8 |
| Name | Halofuginone lactate |
| Molecular Formula | C16H18Br2ClN3O3 |
| Molecular Weight | 495.59 |
| Solubility | Soluble in DMSO ≥2mg/mL |
| Purity | ≥98% |
| Appearance | White to off-white Solid |
| Storage | Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year |
| Target Point | Others |
| Passage | Others |
| Background | HALOFUGINONE LACTATE， a halogenated derivative of febrifugine， is reported to be a compound containing quinazolinone. HALOFUGINONE LACTATE inhibits prolinyl-trNA synthase in an ATP-dependent manner. Halofuginone is a specific inhibitor of type I collagen synthesis and alleviates osteoarthritis by inhibiting TGF-β activity. |
| Unit | Bottle |
| Specification | 1mg |
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no experimental images.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download
